Maternal pesticide exposure disrupts local inhibitory circuits in the reward pathway

T J Baumgartner1, H Teimouri1, A Venkatesh2

  • 1Department of Pharmacology and Toxicology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.

PubMed

Maternal exposure to the pyrethroid pesticide deltamethrin (DM), even below the No Observed Adverse Effect Level (NOAEL), has been increasingly associated with models of neurodevelopmental disorders (NDDs) such as attention-deficit hyperactivity disorder (ADHD) and autism-spectrum disorders (ASD). While recent studies have documented the impact of maternal DM exposure on offspring hippocampal circuits, its effects on the nucleus accumbens (NAc)-a key region implicated in NDDs-remain poorly understood. The NAc is composed of over 80% medium spiny neurons (MSNs), which serve as its sole output and rely on specialized local inhibitory interneurons to regulate firing patterns and synaptic integration. Here, we report subtype-specific dysfunction in parvalbumin-positive (PV+) inhibitory interneurons in the NAc of offspring following maternal DM exposure in mice. Whole-cell patch-clamp recordings from genetically labeled PV+ interneurons revealed that high input-resistance (IR) PV interneurons exhibited unique vulnerability. DM exposure significantly reduced maximum firing frequency and lowered action potential threshold, while low IR PV interneurons remained unaffected. Additionally, the probability of more frequent excitatory synaptic inputs onto high IR PV interneurons were significantly reduced. Mapping our data onto publicly available patch-seq data from a Mini-Atlas revealed that high IR PV interneurons express high levels of Shisa8, an accessory protein regulating AMPA receptor kinetics, and low levels of Grin2A, an NMDA receptor component, suggesting that specific local synaptic circuit disruption in DM-sensitive neurons. Thus, maternal DM exposure selectively impairs a subtype of inhibitory interneurons with unique physiological properties, potentially disrupting synaptic integration in the reward circuit and contributing to NDD-like phenotypes.

Related Concept Videos

Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...